<DOC>
	<DOCNO>NCT00987220</DOCNO>
	<brief_summary>It hypothesize acetylcholinesterase inhibitor , donepezil , increase acute cerebrospinal fluid ( CSF ) actylcholine level healthy volunteer follow 5mg single dose oral administration .</brief_summary>
	<brief_title>Effect Aricept Biomarkers ( Acetylcholine , sAPP Alpha ) In Cerebrospinal Fluid</brief_title>
	<detailed_description>Sampling method base upon estimate intra-subject biomarker variability .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<mesh_term>Acetylcholine</mesh_term>
	<criteria>Healthy male and/or female subject age 18 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) approximately 18 33 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Subject ability understand requirement study , provide write informed consent , abide requirement study . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurological , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . History febrile illness within 5 day prior first study period . History regular alcohol consumption exceed 14 drinks/week ( 1 drink = 5 ounce ( 150 mL ) wine 12 ounce ( 360 mL ) beer 1.5 ounce ( 45 mL ) hard liquor ) within 6 month screen . A positive urine drug screen screen . Use tobacco nicotinecontaining product excess equivalent 5 cigarette per day . Use prescription nonprescription drug , vitamin dietary supplement within 7 day 5 halflives ( whichever longer ) prior first study period . As exception , analgesic , caffeine , nonpharmacological method may use discretion investigator manage symptom related lumbar catheterization . Aspirin , aspirin contain product , nonsteroidal antiinflammatory agent affect platelet function use . Other exception may grant qualified member Pfizer study management . Treatment investigational drug within 30 day precede first study period . Pregnant nursing female ; female childbearing potential unwilling unable use acceptable method nonhormonal contraception ( outline protocol ) least 14 day prior enrollment study completion study . Blood donation approximately 1 pint ( 500 mL ) within 56 day prior dose . Subjects papilledema exam screen Day 0 . Subject laboratory value outside normal range screen Day 0 deem clinically significant investigator . Coagulation index , include PT/aPTT , platelet count must normal . Subjects low spinal malformation , local infection , abnormality would exclude lumbar puncture ( LP ) . Subjects unwilling unable comply Lifestyle guideline present protocol . Other severe acute chronic medical psychiatric condition/status laboratory abnormality may increase risk associate trial participation investigational product administration may interfere interpretation trial result , judgment investigator , would make subject inappropriate entry trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>CSF Biomarkers Acetylcholine</keyword>
</DOC>